Studien & Veröffentlichungen

Medizinische Klinik I

S. Gölder, W. Vogt, H. Lichti, H.C. Rath, A. Kullmann, J. Schölmerich, F. Kullmann
Acceptance of flexible sigmoidoscopy as a screening examination for colorectal cancer in an outpatient clinic
Int. J. Colorectal Dis. 2007, 22: 387-394


C. Ott, N. Ratiu, E. Endlicher, H.C. Rath, C. Gelbmann, J. Schölmerich, F. Kullmann
Self-expanding polyflex plastic stents in esophageal disease: experience in various indications, complications and outcomes
Surg. Endos. 2007, 21: 889-896


S. von Delius, F. Eckel, S. Wagenpfeil, M. Mayr, K. Stock, F. Kullmann, F. Ober-meier, J. Erdmann, R. Schmelz, S. Quasthoff, H. Adelsberger, R.M. Schmid, C. Lersch.
Carbamazepine does not prevent oxaliplatin-related neurotoxicity in patients with advanced colorectal cancer: results of a randomised, controlled, multicenter phase II study
Invest. New Drugs 2007, 25: 173-180


C.M. Gelbmann, P. Rümmele, M. Wimmer, F. Hofstädter, B. Göhlmann, E. Endlicher, F. Kullmann, J. Langgartner, J. Schölmerich
Ischemic-like cholangiopathy with secondary sclerosing cholangitis in critically ill patients (SC-CIP)
Am. J. Gastroenterol. 2007, 102: 1221-1229


K. Schlottmann, F. Klebl, R. Wiest, S. Grüne, F. Kullmann, J. Schölmerich, D. Schacherer
Sonographic guidance of diaphanoscopy-negative percutaneous endoscopic gastrostomy
Endoscopy2007, 39: 686-691


N. Ratiu, C. Gelbmann, H.R. Rath, H. Herfarth, F. Kullmann, J. Schölmerich, H. Messmann
Chromoendoscopy with indigo carmine in flexible sigmoidoscopy screening: does it improve the detection of adenomas in the distal colon and rectum?
J GastrointestinLiver Dis. 2007, 16:153-156


E. Endlicher, M. Troppmann, A. Kullmann, S. Gölder, J. Grossmann, H. Herfarth, K. Schlottmann, F. Kullmann
Efficacy of irinotecan, gemcitabine and 5-fluorouracil in patients with advanvced pancreatic cancer
Oncology 2007, 72: 279-284


R. Meyringer, E. Neumann, M. Judex, M. Landthaler, F. Kullmann, J. Schölmerich, S. Gay, IH Tarner, O. Distler, U. Müller-Ladner
Analysis of gene expression patterns in systemic sclerosis fibroblasts using RNA arbitrarily primed-polymerase chain reaction for differential display
J Rheumatol. 2007, 34: 747-753


P. Piso, M.H. Dahlke, N. Ghali, I. Iesalnieks, M. Loss, F. Popp, P. von Breitenbuch, A. Agha, S.A. Lang, F. Kullmann, H.J. Schlitt
Multimodality treatment of peritoneal carcinomatosis from colorectal cancer: first results of a new German centre for peritoneal surface malignancies
Int J Colorectal Dis. 2007, 22: 1295-1300


I. Zuber-Jerger, N. Zorger, F. Kullmann
Minimal invasive necrosectomy in severe pancreatitis.
ClinGastroenterolHepatol. 2007, 5:e45


I. Zuber-Jerger, E. Endlicher, F. Kullmann
Bleeding jejunal diverticulosis in a patient with myasthenia gravis.
Diagn.Ther.Endosc. 2008, 2008: 156496


G. Huebner, H. Link, C.H. Kohne, M. Stahl, A. Kretzschmar, S. Steinbach, G. Folprecht, H. Bernhard, S.E. Al-Batran, P. Schoffski, C. Burkart, F. Kullmann, B. Otremba, M. Menges, M. Hoffmann, U. Kaiser, A. Aldaoud, A. Jahn; German CUP Study Group
Paclitaxel / carboplatin versus gemcitabine / vinorelbine in patients with adeno- or
undifferentiated carcinoma of unknown primary (CUP) – a randomized prospective phase-II-trialBr. J. Cancer 2009, 100: 44-49


I. Zuber-Jerger, F. Kullmann
Trimming of a Broken Migrated Biliary Metal Stent with the Nd:YAG Laser.
Case Rep Gastroenterol. 2009, 3 : 16-20


I. Zuber-Jerger, E. Endlicher, F. Kullmann, C.M. Gelbmann.
A new grading system to evaluate the risk of endoscopic retrograde cholangio-pancreatography.
J. Gastroenterol. 2009, 44:160-5


F. Kullmann, S. Hollerbach, M.M. Dollinger, J. Harder, M. Fuchs, H. Messmann, J. Trojan, E. Gäbele, A. Hinke, C. Hollerbach, E. Endlicher
Cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in first-line metastatic pancreatic cancer: a multicentre phase II study.
Br. J. Cancer. 2009, 100:1032-1036


Zuber-Jerger, A. Müller, F. Kullmann, C.M. Gelbmann, E. Endlicher, U. Müller-Ladner, M. Fleck
Gastrointestinal manifestation of systemic sclerosis–thickening of the upper gastrointestinal wall detected by endoscopic ultrasound is a valid sign.
Rheumatology (Oxford). 2010, 49: 368-372


S. Boeck, M. Haas, R.P. Laubender, F. Kullmann, C. Klose, C.J. Bruns, R. Wilkowski, P. Stieber, S. Holdenrieder, H. Buchner, U. Mansmann, V. Heinemann
Application of a time-varying covariate model to the analysis of CA 19-9 as serum biomarker in patients with advanced pancreatic cancer.
ClinCancer Res. 2010, 16: 986-994


E. Lippert, F.H. Klebl, F. Schweller , C. Ott, C.M. Gelbmann, J. Schölmerich, E. Endlicher, F. Kullmann
Fibrin glue in the endoscopic treatment of fistulae and anastomotic leakages of the gastrointestinal tract.
Int. J. Colorectal. Dis. 2011, 26: 303-311


M. Moehler, S.E. Al-Batran, T. Andus, M. Anthuber, J. Arends, D. Arnold, D. Aust, P. Baier, G. Baretton, J. Bernhardt , H. Boeing , E. Böhle , C. Bokemeyer , J. Bornschein, W, Budach, E. Burmester, K. Caca, W.A. Diemer, C.F. Dietrich, M. Ebert, A. Eickhoff , C. Ell, J. Fahlke, H. Feussner, R. Fietkau, W. Fischbach, W. Fleig, M. Flentje, H.E. Gabbert, P.R. Galle, M. Geissler, I. Gockel, U. Graeven, L. Grenacher, S. Gross, J.T. Hartmann, M. Heike, V. Heinemann, B. Herbst, T. Herrmann, S. Höcht, R.D. Hofheinz,H. Höfler, T. Höhler, A.H. Hölscher, M. Horneber, J. Hübner, J.R. Izbicki, R. Jakobs, C. Jenssen, S. Kanzler, M. Keller, R. Kiesslich, G. Klautke, J. Körber, B.J. Krause, C. Kuhn, F. Kullmann, H. Lang, H. Link, F. Lordick, K. Ludwig, M. Lutz, R. Mahlberg, P. Malfertheiner, S. Merkel, H. Messmann, H.J. Meyer, S. Mönig , P. Piso, S. Pistorius, R. Porschen, T. Rabenstein, P. Reichardt, K. Ridwelski, C. Röcken, I Roetzer, P. Rohr, W. Schepp, P.M. Schlag, R.M. Schmid, H. Schmidberger, W.H. Schmiegel, H.J. Schmoll, G. Schuch , C. Schuhmacher, K. Schütte, W. Schwenk, M. Selgrad, A. Sendler , J. Seraphin , T. Seufferlein, M. Stahl , H. Stein, C. Stoll, M. Stuschke, A. Tannapfel , R. Tholen , P. Thuss-Patience, K. Treml, U. Vanhoefer, M. Vieth, H. Vogelsang, D. Wagner, U. Wedding, A. Weimann , H. Wilke, C. Wittekind; AWMF.
German S3-guideline „Diagnosis and treatment of esophagogastric cancer
Z. Gastroenterol. 2011, 49: 461-531


C. Giessen, L. Fischer von Weikersthal, A. Hinke, S. Stintzing, F.Kullmann, U. Vehling-Kaiser, J. Mayerle, M. Bangerter, C. Denzlinger, M. Sieber, C. Teschendorf , J. Freiberg-Richter, C. Schulz , D.P. Modest, N. Moosmann, P. Aubele, V. Heinemann
A Randomized, Phase III Trial of Capecitabine plus Bevacizumab (Cape-Bev) versus Capecitabine plus Irinotecan plus Bevacizumab (CAPIRI-Bev) in First-Line Treatment of Metastatic Colorectal Cancer: The AIO KRK 0110 Trial / ML22011 Trial.
BMC Cancer 2011,11: 367


F. Kullmann, A. Hartmann, R. Stöhr, H. Messmann, M.M. Dollinger, J. Trojan, M. Fuchs, S. Hollerbach, J. Harder, M. Troppmann, A. Kutscheidt, E. Endlicher
KRAS mutation in metastatic pancreatic ductal adenocarcinoma: results of a multicenter phase II study evaluating efficacy of cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in first line therapy
Oncology 2011, 81: 3-8


C.C. Schimanski, M. Möhler, M. Schön, E. van Cutsem E, R. Greil, W.O. Bechstein, S. Hegewisch-Becker, G. von Wichert, M. Vöhringer, M. Heike, V. Heinemann, M. Peeters, S. Kanzler, S. Kasper, F. Overkamp, J. Schröder, D. Seehofer, F.Kullmann, B. Linz, I. Schmidtmann, V. Smith-Machnow, I. Gockel, H. Lang, P.R. Galle
LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases: a randomized, placebo-controlled, multicenter, multinational, double-blinded phase II trial
BMC Cancer 2012, 12: 144


S.E. Al-Batran, C. Pauligk, N. Homann, J.T. Hartmann, M. Moehler, S. Probst, V. Rethwisch, J. Stöhlmacher-Williams, N. Prasnikar, S. Hollerbach, C. Bokemeyer, R. Mahlberg, R.D, Hofheinz, K. Luley, F. Kullmann, E. Jäger
The feasibility of triple-drug chemotherapy combination in older adult patients with oesophagogastric cancer: a randomised trial of the ArbeitsgemeinschaftInternistischeOnkologie (FLOT65+)
Eur. J. Cancer 2013, 49: 835-842


A. Atmaca, S.E. Al-Batran, D. Werner, C. Pauligk, T. Güner, A. Koepke, H. Bernhard, T. Wenzel, A.G. Banat, P. Brueck, K. Caca, N. Prasnikar, F. Kullmann, H. GüntherDerigs, M. Koenigsmann, G. Dingeldein, T. Neuhaus, E. Jäger.
A randomisedmulticentre phase II study with cisplatin/docetaxel vs oxaliplatin/ docetaxel as first-line therapy in patients with advanced or metastatic non-small cell lung cancer
Br. J. Cancer 2013, 108; 265-270


M. Haas, V. Heinemann, F. Kullmann, R.P. Laubender, C. Klose, C.J. Bruns, S. Holdenriede, D.P. Modest, C. Schulz, S. Boeck
Prognostic value of CA 19-9, CEA, CRP, LDH and bilirubin levels in locally advanced and metastatic pancreatic cancer: results from a multicenter, pooled analysis of patients receiving palliative chemotherapy.
J Cancer Res ClinOncol. 2013, 139:681-690


T. Seufferlein, M. Porzner, T. Becker, V. Budach, G. Ceyhan, I. Esposito, R. Fietkau, M. Follmann, H. Friess, P. Galle, M. Geißler, M. Glanemann, T. Gress, V. Heinemann, W. Hohenberger, U. Hopt, J. Izbicki, E. Klar, J. Kleeff, I. Kopp, F. Kullmann, T. Langer, J. Langrehr, M. Lerch, M. Löhr, J. Lüttges, M. Lutz, J. Mayerle, P. Michl, P. Möller, M. Molls, M. Münte, M. Nothacker, H. Oettle, S. Post, A. Reinacher-Schick, C. Röcken, E. Roeb, H. Saeger, R. Schmid, W. Schmiegel, MM. Schoenberg, J. Siveke, M. Stuschke, A. Tannapfel, W. Uhl, S. Unverzag, B. van Oorschot, Y. Vashist, J. Werner, E. YekebasS3-guideline exocrine pancreatic cancer.Z Gastroenterol. 2013, 51:1395-440

C. Schenk, F. Kullmann
Karzinogenese des Kolorektalkarzinoms: Welchen Anteil haben die Gene, welchen Anteil hat die Umwelt?
Int. Praxis 2007, 47: 747-752


I. Zuber-Jerger, N. Zorger, C. Paetzel, J. Schoelmerich, S. Feuerbach, F. Kullmann
Minimal invasive therapy in a patient with necrotizing pancreatitis and disrupted duct by percutaneous endoscopy: report of a case and review of literature
Z. Gastroenterol. 2008, 46: 425-430


F. Kullmann
Pankreaskarzinom: Algorithmus der palliativen Chemotherapie
Viszeralmedizin 2010, 26: 91-96

F. Kullmann
Polypen und Polyposissyndrome
In: H. Messmann, Klinische Gastroenterologie, 2011,402-412, Thieme Verlag, Stuttgart-New York


F. Kullmann
Tumoren des Dünndarms
In: H. Messmann, Klinische Gastroenterologie, 2011, 412-417, Thieme Verlag, Stuttgart-New York

Hier können Sie das Publikationsverzeichnis von Prof. Dr. med. Frank Kullmann herunterladen, das Veröffentlichungen bis einschließlich 2006 enthält.